Video » Interview Two-Year Outcomes Of The Randomized Second-Generation Drug-Eluting Stents In Diabetes (SUGAR) Trial September 19, 2022
Video » Interview ACC 2022: The FAME 3 Trial - Quality of Life After Fractional Flow Reserve-guided Stenting Compared with Coronary Bypass Surgery April 3, 2022
Video » Interview FAME 3: A Randomized Trial of FFR-Guided Stenting Compared With CABG November 7, 2021
Video » Interview FAME 3: A Randomized Trial of FFR-Guided Stenting Compared With CABG November 4, 2021
Video » Interview COBRA-REDUCE: A Randomized Trial of a Thromboresistant Polyzene F-Coated Stent With 14 Days DAPT in High-Bleeding Risk Patients October 17, 2020
Video » Interview Assessment of Three-Month and One-Month DAPT After Everolimus-Eluting Stents in High-Bleeding Risk Patients October 15, 2020
Video » Interview Dr. C. Michael Gibson Talks With Dr. Ajay Kirtane About EVOLVE Short DAPT: A Single Arm Study of 3-Month DAPT in Patients at High Bleeding Risk Treated a Bioabsorbable Polymer-Based Everolimus-Eluting Stent September 29, 2019
Video » Interview Dr. C. Michael Gibson Talks With Dr. Stephan Windecker About Onyx ONE: A Randomized Trial of a Durable-Polymer Drug-Eluting Stent vs. a Polymer-Free Drug-Coated Stent in Patients at High Risk of Bleeding Treated With 1-Month DAPT September 28, 2019
Video » Interview Dr. C. Michael Gibson Talks With Dr. Ken Kozuma About MODEL U-SES: A Single-Arm Study of 3-Month DAPT in Patients at High Bleeding Risk Treated With a Bioabsorbable Polymer-Based Sirolimus-Eluting Stent September 27, 2019
Video » Interview ACC 2019: STOPDAPT-2 Trial: One-Month Dual Antiplatelet Therapy Followed by Clopidogrel Monotherapy versus Standard 12-Month Dual Antiplatelet Therapy with Clopidogrel After Drug-Eluting Stent Implantation March 18, 2019
Video » Interview TCT 2018: Dr. C. Michael Gibson talks with Dr. Roxana Mehran about "Stent Wars" September 22, 2018
Video » Interview TCT 2017: Dr. C. Michael Gibson talks with Dr. Dominick Angiolillo about the Surgery After Stent app May 11, 2018